Halozyme Therapeutics Stock Price History

Halozyme Therapeutics Stock Price History Chart

Halozyme Therapeutics November 28, 2024 Stock Price Synopsis

Various analyses of Halozyme Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Halozyme Stock. It can be used to describe the percentage change in the price of Halozyme Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Halozyme Stock. When benchmark price declines in a down market, there may be an uptick in Halozyme Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Halozyme Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Halozyme Stock and then apply it to test your longer-term investment strategies against Halozyme.

Halozyme Stock Price History Data

The price series of Halozyme Therapeutics for the period between Fri, Aug 30, 2024 and Thu, Nov 28, 2024 has a statistical range of 21.85 with a coefficient of variation of 9.77. Under current investment horizon, the daily prices are spread out with arithmetic mean of 56.08. The median price for the last 90 days is 57.24. The company completed 171:40 stock split on 10th of December 2003.

Halozyme Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Halozyme is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Halozyme Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Halozyme Therapeutics stock prices may prove useful in developing a viable investing in Halozyme Therapeutics

Halozyme Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.

Predictive indicators are helping investors to find signals for Halozyme Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Halozyme Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Halozyme to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Halozyme Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. To learn how to invest in Halozyme Stock, please use our How to Invest in Halozyme Therapeutics guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Halozyme Therapeutics. If investors know Halozyme will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Halozyme Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Halozyme Therapeutics is measured differently than its book value, which is the value of Halozyme that is recorded on the company's balance sheet. Investors also form their own opinion of Halozyme Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Halozyme Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Halozyme Therapeutics' market value can be influenced by many factors that don't directly affect Halozyme Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Halozyme Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Halozyme Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Halozyme Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.